Eisler Capital (UK)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$26M Buy
49,945
+2,032
+4% +$1.09M 0.12% 155
2024
Q2
$26M Buy
47,913
+19,969
+71% +$10.6M 0.17% 136
2024
Q1
$14.5M Buy
27,944
+17,126
+158% +$8.52M 0.12% 163
2023
Q4
$5.1M Buy
10,818
+8,820
+441% +$4.08M 0.04% 297
2023
Q3
$870K Buy
+1,998
New +$906K 0.01% 389

Other funds holding ELV

Eisler Capital (UK)'s ELV Position: Q3 2024 in Review

Eisler Capital (UK) increased its Elevance Health (ELV) stake by 30% in Q3 2024, buying an estimated $617K and bringing the position to 5,030 shares worth $2.62M. The position accounts for 0.01% of the portfolio, ranked #422.

Eisler Capital (UK) first reported a position in ELV in Q1 2024 and has held it in 3 quarters since. 1,694 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Eisler Capital (UK) held 5,030 shares of Elevance Health worth $2.62M as of Q3 2024.
  • Eisler Capital (UK) bought 1,155 Elevance Health shares in Q3 2024, an estimated $617K.
  • Elevance Health made up 0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #422 holding.
  • Eisler Capital (UK) first reported a position in Elevance Health in Q1 2024 and has held it in 3 quarters since.
  • 1,694 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.